Federated Hermes’s PAVmed PAVM Stock Holding History

Federated Hermes’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-168	Closed	-$484K	–	2291
2021 Q2	$484K	Buy	+168	New	+$397K	﹤0.01%	1516
2021 Q1	–	Hold	0	–	–	–	2183

Other funds holding PAVM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Federated Hermes's PAVM Position: Q3 2021 in Review

Federated Hermes sold out of PAVmed (PAVM) in Q3 2021, closing a stake of 168 shares — an estimated $484K sold.

Federated Hermes first reported a position in PAVM in Q2 2021 and held it in 1 quarter. The position peaked at $484K in Q2 2021. 107 funds tracked by Wall St. Rank hold PAVM as of Q3 2021.

Federated Hermes reported no remaining PAVmed position as of Q3 2021 after selling out during the quarter.
Federated Hermes sold 168 PAVmed shares in Q3 2021, an estimated $484K.
Federated Hermes first reported a position in PAVmed in Q2 2021 and held it in 1 quarter.
Federated Hermes's PAVmed position peaked at $484K in Q2 2021.
107 funds tracked by Wall St. Rank held PAVmed as of Q3 2021.

Based on Federated Hermes's 13F filing for Q3 2021, filed 15 Nov 2021.